Automatic injector: Current Opportunities and Future Growth Areas
Since the introduction of the automatic injector (autoinjectors) device in 1980s, their numerous benefits, such as ease-of-use, reduced chances of dosing errors, integrated safety mechanisms, and almost negligible risk of needlestick injuries, have been widely recognized among consumers and healthcare service providers. Automatic injector are also considered to be potential life cycle management tool. Drugs nearing patent expiry can be developed for delivery using an automatic injector and retain market exclusivity as a combination product. Various initiatives are underway to make these devices even more patient-friendly; in fact, between January 2013 and December 2017, close to 3,800 patents have been published in this domain, indicating the rapid pace at which research is being carried out in this field.
The Market Landscape of Autoinjectors is Steadily Widening
Over 85 unique autoinjector devices and 75 drug-autoinjector combination products are currently available in the market.
The Interest is Validated by a Large Number of Recently Filed Patents
As a result of the widening research interest, close to 3,800 patents have been filed recently; automatic injector devices, with improved features, are gradually becoming mainstream
Healthy Competition Among Stakeholders is Fostering Technological Advances
Ongoing innovation has led to the development of robust technology platforms that have significantly strengthened the growing product landscape in this domain.
The Development Focus is Spread Across a Variety of Target Therapeutic Areas
Several combination products are already approved for a diverse array of indications; majority of them are disposable in nature and designed for subcutaneous drug delivery
Our Proprietary Analysis Reveals Several Drugs that are Suited for Delivery via Autoinjectors
A detailed evaluation of both marketed / pipeline products highlights several drug candidates that are suited for delivery via autoinjectors.
We Expect the Market to Steadily Evolve Over the Next Decade …
Overall, the global autoinjectors market is poised to grow at a steady pace in the mid-long term; the opportunity is likely to be well-distributed across different regions of the world
… As Devices with New Features Get Commercialized for A Wider Pool of Indications
Rising incidence of chronic conditions is expected to drive future growth; devices offering subcutaneous drug delivery will continue to capture over 90% of the market’s share.
For more details, you can also download the SAMPLE REPORT on automatic injector by Roots Analysis.
Drug Bioavailability Enhancement: Growth Opportunities
TPD and the Rise of Kymera Therapeutics
Intranasal Drugs: A Deeper Look into Service Providers Landscape
About Author
Arun_Gupta
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.